Market revenue in 2023 | USD 555.4 million |
Market revenue in 2030 | USD 808.1 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 75.86% in 2023. Horizon Databook has segmented the Colombia healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The government of Colombia is undertaking various initiatives to make Colombia more attractive for clinical research. The country’s National Institute of Food and Drug Monitoring (INVIMA), in April 2016, announced the reduction of time for evaluation of study protocol and approval process.
The timelines for clinical research associated with investigational drugs have been reduced to 60 days from an average 135 days. Furthermore, as per INVIMA, conducting research in Colombia is cost-effective, which results in more than 30% savings as compared to the U.S. and Europe.
The availability of a large patient pool, nearly 600 million people, also serve as a driving factor to conduct clinical trials in this country. Hence, creating demand for healthcare contract research organizations.
Horizon Databook provides a detailed overview of country-level data and insights on the Colombia healthcare contract research organization market , including forecasts for subscribers. This country databook contains high-level insights into Colombia healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account